XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
COMMON
ADDITIONAL PAID-IN CAPITAL
ACCUMULATED DEFICIT
ACCUMULATED OTHER COMPREHENSIVE GAIN (LOSS)
Beginning balance (in shares) at Dec. 31, 2022   37,837,369      
Beginning balance at Dec. 31, 2022 $ 169,317 $ 4 $ 330,208 $ (160,681) $ (214)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 5,737   5,737    
Issuance of common stock under the stock purchase plan (in shares)   43,423      
Issuance of common stock from the stock purchase plan 209   209    
Issuance of common stock under the stock award plan (in shares)   1,219      
Forfeiture of restricted common stock (in shares)   (91,155)      
Net loss (35,948)     (35,948)  
Other comprehensive loss (58)       (58)
Ending balance (in shares) at Jun. 30, 2023   37,790,856      
Ending balance at Jun. 30, 2023 139,257 $ 4 336,154 (196,629) (272)
Beginning balance (in shares) at Mar. 31, 2023   37,746,214      
Beginning balance at Mar. 31, 2023 155,197 $ 4 333,253 (177,999) (61)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 2,692   2,692    
Issuance of common stock under the stock purchase plan (in shares)   43,423      
Issuance of common stock from the stock purchase plan 209   209    
Issuance of common stock under the stock award plan (in shares)   1,219      
Net loss (18,630)     (18,630)  
Other comprehensive loss (211)       (211)
Ending balance (in shares) at Jun. 30, 2023   37,790,856      
Ending balance at Jun. 30, 2023 $ 139,257 $ 4 336,154 (196,629) (272)
Beginning balance (in shares) at Dec. 31, 2023 37,829,565 37,829,565      
Beginning balance at Dec. 31, 2023 $ 106,184 $ 4 341,410 (235,245) 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 4,003   4,003    
Issuance of common stock upon completion of a securities purchase agreement, net of offering costs (in shares)   3,636,363      
Issuance of common stock upon completion of a securities purchase agreement, net of offering costs 5,137   5,137    
Issuance of common stock under the stock purchase plan (in shares)   38,289      
Issuance of common stock from the stock purchase plan 44   44    
Issuance of common stock under the stock award plan (in shares)   1,925      
Forfeiture of restricted common stock (in shares)   (18,556)      
Net loss (35,265)     (35,265)  
Other comprehensive loss $ (86)       (86)
Ending balance (in shares) at Jun. 30, 2024 41,487,586 41,487,586      
Ending balance at Jun. 30, 2024 $ 80,017 $ 4 350,594 (270,510) (71)
Beginning balance (in shares) at Mar. 31, 2024   37,811,970      
Beginning balance at Mar. 31, 2024 89,157 $ 4 343,498 (254,274) (71)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 1,915   1,915    
Issuance of common stock upon completion of a securities purchase agreement, net of offering costs (in shares)   3,636,363      
Issuance of common stock upon completion of a securities purchase agreement, net of offering costs 5,137   5,137    
Issuance of common stock under the stock purchase plan (in shares)   38,289      
Issuance of common stock from the stock purchase plan 44   44    
Issuance of common stock under the stock award plan (in shares)   1,925      
Forfeiture of restricted common stock (in shares)   (961)      
Net loss (16,236)     (16,236)  
Other comprehensive loss $ 0        
Ending balance (in shares) at Jun. 30, 2024 41,487,586 41,487,586      
Ending balance at Jun. 30, 2024 $ 80,017 $ 4 $ 350,594 $ (270,510) $ (71)